Table 2.

Toxicity of the combination therapy with thalidomide and dexamethasone

	n/N	%	95% CI
Constipation	140/379	37	32–42
Thromboembolic event	15/308	5	3–8
Somnolence	93/352	26	22–31
Neuropathy	101/373	27	23–32
Depression	27/265	10	7–14
Discontinuation because of adverse event	40/297	13	10–18

n, events; N, total number of patients for which the incidence of this adverse effect was reported.